Drugs: Pressemitteilungen - Kategorie - Seite 19

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Theravance Biopharma Announces New Employment Inducement Awards

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 09/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase ...

Insys Therapeutics to Present at 10th Annual Wells Fargo Healthcare Conference

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 09/01/15 -- Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ: INSY) today announced that Michael Babich, President and Chief Executive O ...

GUD Medison Taken at Knight

MONTREAL, CANADA and PETAH TIKVA, ISRAEL: MONTREAL, CANADA and PETAH TIKVA, ISRAEL -- (Marketwired) -- 08/31/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, and Medison Bi ...

Advaxis Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through Direct Investments From Knight and Sectoral Asset Management

PRINCETON, NEW JERSEY and MONTREAL, QUEBEC: Licensing agreement provides Knight commercial rights in Canada to Advaxis's product portfolio including axalimogene filolisbac (ADXS-HPV), ADXS-PSA and ADXS-HER2 Advaxis is eligible to receive u ...

MSI Methylation Sciences Inc. (MSI) Treats the Last Patient in its Horizon Trial and Receives Four Patents to Support its Proprietary Treatment Strada(TM) for Major Depressive Disorder (MDD)

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/25/15 -- MSI Methylation Sciences Inc., a pharmaceutical company developing a once-daily oral, small molecule therapy for adjunctive treatment of ma ...

NEMO Ascends to New High Water Mark for Knight

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/24/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...

Insys Therapeutics, Inc. Files Citizen Petition With the Drug Enforcement Administration (DEA) to Reschedule Its Synthetic Pharmaceutical Cannabidiol (CBD)

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 08/18/15 -- Insys Therapeutics, Inc. ("Insys" or "the Company") (NASDAQ: INSY) today announced it has filed a Citizen Petition with the Drug Enforc ...

Titan Pharmaceuticals Reports Second Quarter 2015 Financial Results

SOUTH SAN FRANCISCO, CA: Management Team to Host Conference Call August 17 at 1 p.m. EDT /10 a.m. PDT ...

Knight Reports Second Quarter 2015 Results

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/12/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today repor ...

Knight and LFB S.A. Announce Filing of New Drug Submission for ATryn(R)

MONTREAL, CANADA and LES ULIS, FRANCE: MONTREAL, CANADA and LES ULIS, FRANCE -- (Marketwired) -- 08/06/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical ...

GSK Receives Approval for BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/06/15 -- GSK (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) announce the approval in Canada of BREO® ELLIPTA® (fluticasone ...

Marina Biotech Announces $1.1 MM Convertible Preferred Stock Financing

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 08/06/15 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced that the ...

Insys Therapeutics Reports Second Quarter 2015 Results

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 08/06/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced financial results for the three- and six-month perio ...

Knight Sparks Ember Partnership

MONTREAL, CANADA and NEW YORK, NEW YORK: MONTREAL, CANADA and NEW YORK, NEW YORK -- (Marketwired) -- 08/05/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company and Ember Therap ...

Corcept Therapeutics Announces Second Quarter 2015 Results and Provides Corporate Update

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 08/05/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Per-share net loss in the second quarter narrows to $0.02, from $0.07 in the same period last yearExclud ...

Romark Laboratories and Lupin Pharmaceuticals Respond to Recent Cryptosporidium (Crypto) Outbreak in Knoxville

TAMPA, FL and BALTIMORE, MD: Infectious Disease Expert Urges Those Experiencing Symptoms to Consult Their Doctors for Proper Care ...

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms

PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 08/04/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has ...

Romark Laboratories and Lupin Pharmaceuticals Respond to Recent Cryptosporidium (Crypto) Outbreak in Tennessee

TAMPA, FL and BALTIMORE, MD: Infectious Disease Expert Urges Those Experiencing Symptoms to Consult Their Doctors for Proper Care ...

The Peace Naturals Project Receives First MMPR Cannabis Oil Licence to Be Issued by Health Canada Under Section 56 Exemption

STAYNER, ONTARIO: STAYNER, ONTARIO -- (Marketwired) -- 07/31/15 -- The Peace Naturals Project Inc., the first company to be licenced by Health Canada to produce and sell medicinal Cannabis to Canadians under the Fede ...


Seite 19 von 66:  « ..  18 19 20  21  22  23  24  25  26  27  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z